A clinical-stage biotechnology company focused on developing therapies for breast cancer and other breast health conditions. Its lead programs center on endocrine-driven breast cancer treatments, including oral endoxifen, which is being evaluated in multiple clinical studies. Investors monitor the c...
No congressional trades have been disclosed for Atossa Genetics Inc (ATOX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.